Display options
Cite
Mohammad G, Mairaj Siddiquei M, Imtiaz Nawaz M, et al. The ERK1/2 Inhibitor U0126 Attenuates Diabetes-Induced Upregulation of MMP-9 and Biomarkers of Inflammation in the Retina. J Diabetes Res. 2013;2013:658548doi: 10.1155/2013/658548.
Mohammad, G., Mairaj Siddiquei, M., Imtiaz Nawaz, M., & Abu El-Asrar, A. M. (2013). The ERK1/2 Inhibitor U0126 Attenuates Diabetes-Induced Upregulation of MMP-9 and Biomarkers of Inflammation in the Retina. Journal of diabetes research, 2013658548. https://doi.org/10.1155/2013/658548
Mohammad, Ghulam, et al. "The ERK1/2 Inhibitor U0126 Attenuates Diabetes-Induced Upregulation of MMP-9 and Biomarkers of Inflammation in the Retina." Journal of diabetes research vol. 2013 (2013): 658548. doi: https://doi.org/10.1155/2013/658548
Mohammad G, Mairaj Siddiquei M, Imtiaz Nawaz M, Abu El-Asrar AM. The ERK1/2 Inhibitor U0126 Attenuates Diabetes-Induced Upregulation of MMP-9 and Biomarkers of Inflammation in the Retina. J Diabetes Res. 2013;2013:658548. doi: 10.1155/2013/658548. Epub 2013 Apr 10. PMID: 23671886; PMCID: PMC3647581.
Copy Download .nbib Format: NLM
Share it on

J Diabetes Res. 2013;2013:658548. doi: 10.1155/2013/658548. Epub 2013 Apr 10.

The ERK1/2 Inhibitor U0126 Attenuates Diabetes-Induced Upregulation of MMP-9 and Biomarkers of Inflammation in the Retina.

Journal of diabetes research

Ghulam Mohammad, Mohammad Mairaj Siddiquei, Mohammad Imtiaz Nawaz, Ahmed M Abu El-Asrar

Affiliations

  1. Department of Ophthalmology, College of Medicine, King Saud University, P.O. Box 245, Riyadh 11411, Saudi Arabia.

PMID: 23671886 PMCID: PMC3647581 DOI: 10.1155/2013/658548

Abstract

This study was conducted to determine the expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in a time-dependent manner and the effect of extracellular-signal-regulated kinases-1/2 (ERK1/2) inhibition on the expressions of MMP-9, TIMP-1, and inflammatory biomarkers in the retinas of diabetic rats. The expression of MMP-9 was quantified by zymography, and the mRNA level of MMP-9 and TIMP-1 was quantified by RT-PCR. The expression of inducible nitric oxide synthase (iNOS), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF- α ) was examined by Western blot analysis. MMP-9 expression was significantly higher in diabetic rat retinas compared to controls at all time points.TIMP-1 expression was nonsignificantly upregulated at 1week of diabetes and was significantly downregulated at 4 and 12 weeks of diabetes. Intravitreal administration of the ERK1/2 inhibitor U0126 prior to induction of diabetes decreased ERK1/2 activation, attenuated diabetes-induced upregulation of MMP-9, iNOS, IL-6, and TNF- α and upregulated TIMP-1 expression. In MMP-9 knockout mice, diabetes had no effect on retinal iNOS expression and its level remained unchanged. These data provide evidence that ERK1/2 signaling pathway is involved in MMP-9, iNOS, IL-6, and TNF- α induction in diabetic retinas and suggest that ERK1/2 can be a novel therapeutic target in diabetic retinopathy.

References

  1. J Clin Invest. 1999 Dec;104(11):1507-15 - PubMed
  2. Invest Ophthalmol Vis Sci. 2010 Oct;51(10):5226-33 - PubMed
  3. Arthritis Rheum. 2009 Nov 15;61(11):1580-5 - PubMed
  4. Nat Rev Drug Discov. 2009 May;8(5):417-29 - PubMed
  5. Oncogene. 2002 Aug 15;21(36):5601-8 - PubMed
  6. Arterioscler Thromb Vasc Biol. 2000 Dec;20(12):2527-32 - PubMed
  7. Diabetes. 2004 Nov;53(11):2960-7 - PubMed
  8. Lab Invest. 2005 May;85(5):597-607 - PubMed
  9. Retina. 2001;21(1):28-33 - PubMed
  10. Mediators Inflamm. 2000;9(5):243-8 - PubMed
  11. Exp Eye Res. 2013 Feb;107:101-9 - PubMed
  12. Invest Ophthalmol Vis Sci. 2010 Aug;51(8):4320-6 - PubMed
  13. FASEB J. 2002 Mar;16(3):438-40 - PubMed
  14. J Cell Physiol. 2012 Feb;227(2):867-76 - PubMed
  15. Am J Pathol. 2002 Feb;160(2):501-9 - PubMed
  16. Am J Physiol Regul Integr Comp Physiol. 2004 Oct;287(4):R735-41 - PubMed
  17. Nitric Oxide. 2002 May;6(3):295-304 - PubMed
  18. J Diabetes Complications. 2011 Nov-Dec;25(6):393-7 - PubMed
  19. J Cell Physiol. 2012 Mar;227(3):1052-61 - PubMed
  20. FASEB J. 2008 Apr;22(4):954-65 - PubMed
  21. J Med Food. 2012 Apr;15(4):391-8 - PubMed
  22. Middle East Afr J Ophthalmol. 2012 Jan;19(1):70-4 - PubMed
  23. Angiogenesis. 2008;11(1):91-9 - PubMed
  24. J Biol Chem. 2009 Sep 18;284(38):25854-66 - PubMed
  25. J Ocul Biol Dis Infor. 2012 Jul 06;5(1):1-8 - PubMed
  26. Diabetes. 2011 Jan;60(1):9-16 - PubMed
  27. FASEB J. 2004 Sep;18(12):1450-2 - PubMed
  28. Expert Opin Ther Targets. 2011 Apr;15(4):357-64 - PubMed
  29. Eur Cytokine Netw. 2006 Sep;17(3):155-65 - PubMed
  30. Brain Res. 2007 Dec;1186:12-20 - PubMed
  31. Arthritis Res Ther. 2006;8(6):R172 - PubMed
  32. Invest Ophthalmol Vis Sci. 2001 Sep;42(10):2408-13 - PubMed
  33. Arthritis Rheum. 1999 Apr;42(4):609-21 - PubMed
  34. Angiology. 2005 Mar-Apr;56(2):173-89 - PubMed
  35. J Cell Biol. 1993 Sep;122(5):1079-88 - PubMed
  36. Diabetes. 2011 Nov;60(11):3023-33 - PubMed
  37. Exp Eye Res. 2006 Aug;83(2):401-7 - PubMed
  38. Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10836-41 - PubMed
  39. Am J Ophthalmol. 2001 Oct;132(4):551-6 - PubMed
  40. Glia. 2003 Sep;43(3):254-64 - PubMed
  41. Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20262-7 - PubMed
  42. Crit Rev Clin Lab Sci. 2008;45(3):291-338 - PubMed
  43. Am J Ophthalmol. 1998 Jun;125(6):844-51 - PubMed
  44. Mol Cell Biol. 1992 Mar;12(3):915-27 - PubMed
  45. Eye (Lond). 2006 Dec;20(12):1366-9 - PubMed
  46. Kidney Int. 2005 Feb;67(2):458-66 - PubMed
  47. Diabetes. 2007 Feb;56(2):337-45 - PubMed
  48. J Biol Chem. 1999 Jul 30;274(31):21491-4 - PubMed
  49. Exp Diabetes Res. 2007;2007:31867 - PubMed
  50. Invest Ophthalmol Vis Sci. 2000 Apr;41(5):1153-8 - PubMed
  51. Nature. 2005 Dec 15;438(7070):960-6 - PubMed
  52. J Neurochem. 2008 Jul;106(2):770-80 - PubMed
  53. J Neuroinflammation. 2010 Feb 26;7:14 - PubMed
  54. N Engl J Med. 2004 Jan 1;350(1):48-58 - PubMed
  55. Invest Ophthalmol Vis Sci. 2004 Aug;45(8):2760-6 - PubMed
  56. J Neurosci. 2006 May 31;26(22):5996-6003 - PubMed
  57. Middle East Afr J Ophthalmol. 2012 Jan;19(1):52-9 - PubMed
  58. Circ Res. 2001 Jun 22;88(12):1291-8 - PubMed

Publication Types